Richard William Scalzo insider trades

Open-market stock purchases and sales by Richard William Scalzo, Chief Financial Officer at Crescent Biopharma, Inc, from SEC Form 4 filings since Sep 16, 2020.

Recent trades

DateStockTradeValue
Sep 16, 2026CBIO Crescent Biopharma, IncSold$10.2K
Jun 22, 2026CBIO Crescent Biopharma, IncSold$20K
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—

Companies traded

  • CBIO Crescent Biopharma, Inc: 2 sales, last Sep 16, 2026
  • DYN Dyne Therapeutics, Inc: 40 sales, last Mar 11, 2025

Get free alerts when Richard William Scalzo files a new trade →